SPHINGO- AND PHOSPHO-LIPIDS METABOLISM IMPAIRMENT AS A POTENTIAL THERAPEUTIC TARGET IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) NEUROPATHY

被引：0
|
作者：
Capodivento, G. [1 ,2 ]
Visigalli, D. [1 ,2 ]
Basit, A. [3 ]
Pastore, V. P. [4 ]
Armirotti, A. [3 ]
Schenone, A. [1 ,2 ]
Nobbio, L. [1 ,2 ]
机构：
[1] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy
[2] Univ Genoa, CEBR, Genoa, Italy
[3] Ist Italiano Tecnol IIT, Drug Discovery & Dev Dept, Genoa, Italy
[4] Univ Genoa, Dept Informat Bioengn Robot & Syst Engn DIBRIS, Genoa, Italy
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2015年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [41] Neurofibromatosis type 1 associated with Charcot-Marie-Tooth type 1A
    Koc, Filiz
    Guzel, A. Irfan
    JOURNAL OF DERMATOLOGY, 2009, 36 (05): : 306 - 311
  • [42] THE DIAGNOSIS AND PREVALENCE OF DUPLICATION OF THE CMT1A LOCUS IN CHARCOT-MARIE-TOOTH TYPE-I DISEASE
    BORT, S
    SEVILLA, T
    VILCHEZ, JJ
    PRIETO, F
    PALAU, F
    MEDICINA CLINICA, 1995, 104 (17): : 648 - 652
  • [43] WORK IMPACTS IN PATIENTS WITH CHARCOT-MARIE-TOOTH DISEASE TYPE 1A (CMT1A): FINDINGS FROM A REAL-WORLD DIGITAL STUDY
    Thomas, Florian
    Sevilla, Teresa
    Sivera, Rafael
    Genovese, Filippo
    Gray, Amy
    Bull, Simon
    Paoli, Xavier
    Senechal, Thomas
    Day, Laura
    Llewellyn, Samuel
    Larkin, Mark
    Boutalbi, Youcef
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S16 - S17
  • [44] CHARCOT-MARIE-TOOTH TYPE I DISEASE (CMT-1)
    Adoukonou, Thierry Armel
    Vallat, Jean-Michel
    Mathis, Stephane
    AFRICAN JOURNAL OF NEUROLOGICAL SCIENCES, 2015, 34 (01): : 72 - 84
  • [45] Charcot-Marie-Tooth type 1A disease and therapy with ascorbic acid: The CMT-TRIAAL
    Pareyson, D.
    Schenone, A.
    Rizzuto, N.
    Fabrizi, G.
    Santoro, L.
    Vita, G.
    Quattrone, A.
    Padua, L.
    Gemignani, F.
    Visioli, F.
    Solari, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2007, 12 (02) : 166 - 167
  • [46] Unilateral oculomotor palsy in Charcot-Marie-Tooth disease lA (CMT 1A)
    Posa, A.
    Emmer, A.
    Kornhuber, M. E.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2017, 155 : 20 - 21
  • [47] Coexistence of Charcot-Marie-Tooth disease type 1A and anti-MAG neuropathy
    Piscosquito, Giuseppe
    Salsano, Ettore
    Ciano, Claudia
    Palamara, Luisa
    Morbin, Michela
    Pareyson, Davide
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 (02) : 185 - 188
  • [48] Influence of comorbidities on the phenotype of patients affected by Charcot-Marie-Tooth neuropathy type 1A
    Ursino, Giulia
    Antonia Alberti, M.
    Grandis, Marina
    Reni, Lizia
    Pareyson, Davide
    Bellone, Emilia
    Gemelli, Chiara
    Sabatelli, Mario
    Pisciotta, Chiara
    Luigetti, Marco
    Santoro, Lucio
    Massollo, Laura
    Schenone, Angelo
    NEUROMUSCULAR DISORDERS, 2013, 23 (11) : 902 - 906
  • [49] Clinical and electrophysiological evaluation of 222 patients with Charcot-Marie-Tooth disease type 1A recruited in the CMT-TRIAAL (ascorbic acid therapy for Charcot-Marie-Tooth 1A disease)
    Pareyson, D.
    Schenone, A.
    Rizzuto, N.
    Fabrizi, G. M.
    Santoro, L.
    Vita, G.
    Quattrone, A.
    Padua, L.
    Gemignani, F.
    Visioli, F.
    Calabrese, D.
    Solari, A.
    JOURNAL OF NEUROLOGY, 2008, 255 : 104 - 105
  • [50] Charcot-Marie-Tooth disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP):: Reliable detection of the CMT1A duplication and HNPP deletion using 8 microsatellite markers in 2 multiplex PCRs
    Seeman, P
    Mazanec, R
    Zidar, J
    Hrusáková, S
    Ctvrtecková, M
    Rautenstrauss, B
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2000, 6 (04) : 421 - 426
12345